Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DFE Pharma, Harro Höfliger and Sterling Establish Joint Initiative | Contract Pharma

What are you searching for?

Sign in
Breaking News

DFE Pharma, Harro Höfliger and Sterling Establish Joint Initiative

INTO provides R&D services to pharma companies in the respiratory field, making formulation development simpler, faster, & easier to manage.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) have partnered to establish “Inhalation Together” (INTO) in the field of dry powder inhalation (DPI).
 
This initiative provides R&D services to pharmaceutical companies in the respiratory field, making formulation development simpler, faster, and easier to manage. INTO offers a coordinated and aligned suite of services, leveraging the expertise and complementary skill sets of its three partners.
 
Developing a DPI formulation is a complex process, with a strong interdependency between process, powder, device and patient. This increases the need for high-quality customer support. To address the specific customer needs, the INTO services range from initial consultancy and problem statement development to a stepwise formulation development program. The individual services include, among others, solid-state characterization and sono-crystallization of APIs and studies to optimize formulation, blending, and filling. The three INTO partners can also offer extensive consultancy services.
 
“I am very excited about the INTO initiative because it increases speed to market and reduces the complexity of formulation and process development. The three companies have a very good understanding of the critical aspects of development and manufacture of DPI products, therefore, adding significant value to our customers,” explained Martti Hedman, CEO of DFE Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics